Related by context. Frequent words. (Click for all words.) 72 Initiates Phase II 72 NASDAQ CRXL 72 Paris IPN 71 Completes Patient Enrollment 71 Enrolls First 71 Inc. Nasdaq SUPG 71 Crucell NV NYSE Euronext 71 Receives Orphan Drug Designation 69 Paris EURONEXT SAN 69 Presents Positive 69 Crucell NV Euronext 69 Inc. NASDAQ QLTI 69 MorphoSys AG FSE MOR 68 Nasdaq OSIP 68 please visit http:/www.supergen.com 68 Miscellaneous #.#.# Release 67 Am J Obstet 67 ticker symbol OPERA 67 Inc. Nasdaq TRMS 67 Joins OTCQX 67 Nasdaq CRXL 66 Roche SIX RO 66 Announces FDA Clearance 66 Files Shelf Registration Statement 66 Inc Therapeutic Competitors 66 Marcus Gronholm BP 66 Strengthens Position 66 R sorafenib tablets 66 Regulatory Disclosure 66 ticker symbol AMS 66 Jumps Higher 66 Inc. Nasdaq IMGN 66 PINNACLEDIGEST.COM S PAST PERFORMANCE 66 By MARK CARREAU 66 Active Biotech AB 66 Completes Enrollment 66 Nasdaq PSTI 66 Completes Tender Offer 66 Welcomes Analyst Initiation 66 * Azixa 65 By SHELBY G. 65 By XiaoBing #-#-# 65 LYON France BUSINESS WIRE 65 Takeda Kyowa Hakko Kirin 65 Develop Novel 65 SMARTREND WATCHING FOR 65 Biomagnetics Diagnostics Corporation 65 www.crucell.com 65 Joseph Levi Esq 65 symbol WTWO 65 Boozy nightKaty Perry 65 FREE Whitepaper 65 PRAECIS PHARMACEUTICALS INCORPORATED 65 By Sylvie Belmond 65 please visit http:/www.osip.com 65 Abraxis trades 65 NYSE SHR 65 By Steve Walentik 65 CHEAP ONLINE PHARMACY LOW 65 Application MAA 65 Submits Application 65 DGAP ein Unternehmen der 65 Meets Primary Endpoint 65 W2 Energy trades 64 Staff Writer larry@gaffneyledger.com 64 dem Ziel der europaweiten 64 Announces Licensing Agreement 64 PRICE GREAT DISCOUNT FREE 64 Evotec AG Frankfurt 64 Sanofi aventis EURONEXT SAN 64 Advancing Drugs 64 Attracting Bullish Investors 64 Regains Compliance 64 Response Biomedical Corporation 64 Bearish Speculation 64 By RICHARD JUSTICE 64 symbol TVL 64 Purchase CIALIS Need 64 oncolytic virus therapies 64 Q3 Loss Narrows 64 www.vivus.com 64 CRXL 64 Exelixis logo 64 Company Nasdaq PRGO 64 Regains Compliance With 64 developing Zerenex TM 64 www.twitter.com otcadvisors 64 Disclaimer c 64 By PETER LARSEN 64 Earnings Postmortem 64 FDA Accepts 64 MITTEILUNG UEBERMITTELT VON BUSINESS 64 Shareholders Approve Acquisition 64 By Thomas Gryta 64 Drug Candidate 64 Nasdaq ENZN 64 By Megan Ainscow 64 music attenti 64 -leukemias 64 kpender@sfchronicle.com 64 CRWEWallstreet.com Stock Report